These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23165619)
61. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage. Neal RE; Smith RL; Kavnoudias H; Rosenfeldt F; Ou R; Mclean CA; Davalos RV; Thomson KR Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1638-1645. PubMed ID: 23942593 [TBL] [Abstract][Full Text] [Related]
62. Electroporation (revival of direct current ablation): new approach for increasing epicardial ablation safety in close proximity to a coronary artery. Nakagawa H; Jackman WM Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):779-80. PubMed ID: 25336363 [No Abstract] [Full Text] [Related]
63. Defining the Optimal Use of Ablation for Metastatic Colorectal Cancer to the Liver Without High-Level Evidence. Diaz-Nieto R; Fenwick S; Malik H; Poston G Curr Treat Options Oncol; 2017 Feb; 18(2):8. PubMed ID: 28214976 [TBL] [Abstract][Full Text] [Related]
64. [Radiofrequency ablation of malignant liver tumors]. Klug R; Kurz F; Aufschnaiter M Wien Klin Wochenschr; 2006 Jun; 118 Suppl 3():18-21. PubMed ID: 17073075 [No Abstract] [Full Text] [Related]
65. Locally ablative therapies for primary and metastatic liver cancer. Li D; Kang J; Madoff DC Expert Rev Anticancer Ther; 2014 Aug; 14(8):931-45. PubMed ID: 24746315 [TBL] [Abstract][Full Text] [Related]
66. Half-deployed method: percutaneous radiofrequency ablation therapy using clustered electrodes for malignant liver tumors proximal to large vessels. Horigome H; Nomura T; Nakao H; Itoh M AJR Am J Roentgenol; 2001 Oct; 177(4):948. PubMed ID: 11566715 [No Abstract] [Full Text] [Related]
67. Local recurrence of colorectal liver metastases following RFA--can we do BETA? Dobbins C; Strickland AD; Maddern GJ ANZ J Surg; 2010; 80(7-8):482-3. PubMed ID: 20795957 [No Abstract] [Full Text] [Related]
69. Anaesthetic management during open and percutaneous irreversible electroporation. Nielsen K; Scheffer HJ; Vieveen JM; van Tilborg AA; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR; Bouwman RA Br J Anaesth; 2014 Dec; 113(6):985-92. PubMed ID: 25173767 [TBL] [Abstract][Full Text] [Related]
70. Myocardial lesion size after epicardial electroporation catheter ablation after subxiphoid puncture. Neven K; van Driel V; van Wessel H; van Es R; Doevendans PA; Wittkampf F Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):728-33. PubMed ID: 25015945 [TBL] [Abstract][Full Text] [Related]
71. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. Narayanan G; Hosein PJ; Arora G; Barbery KJ; Froud T; Livingstone AS; Franceschi D; Rocha Lima CM; Yrizarry J J Vasc Interv Radiol; 2012 Dec; 23(12):1613-21. PubMed ID: 23177107 [TBL] [Abstract][Full Text] [Related]